Overview
- 9 inspections across 9 sites are on record.
- 26 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-07.
At a glance
Inspections
9
Sites
9
Observations
26
Career since
Mar 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| DPT Laboratories, Ltd. | 7 Feb 2020 | Human Drugs | View 483 → |
| Aveva Drug Delivery Systems Inc. | 26 Jul 2019 | Human Drugs | View 483 → |
| CATALENT U.K. SWINDON ZYDIS LIMITED | 23 Aug 2018 | Human Drugs | On file |
| Novo Nordisk Production Belgium SA | 31 Jul 2018 | Medical Devices & Rad Health | On file |
| Mithra Pharmaceuticals Cdmo SA | 1 Jun 2018 | Human Drugs | On file |
Sites inspected
DPT Laboratories, Ltd.San Antonio, United States1 insp.
Aveva Drug Delivery Systems Inc.Miramar, United States1 insp.
CATALENT U.K. SWINDON ZYDIS LIMITEDSwindon, United Kingdom1 insp.
Novo Nordisk Production Belgium SABrussels, Belgium1 insp.
Mithra Pharmaceuticals Cdmo SAFlemalle, Belgium1 insp.
Co-investigators
Investigators who share inspections with this person.
Stephen D Brown1 shared
Dipti Kalra1 shared
Haley H Seymour1 shared
Richard A Lyght1 shared
Jennifer Lalama1 shared
John A Gonzalez1 shared
Lisa B Orr1 shared
Yvins Dezan1 shared
James W Whitney1 shared
Emmanuel J Ramos1 shared
Full investigator report
Get the verbatim findings behind Youmin Wang's 26 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site